FINN Partners adds Medika Life to it's Omni-Channel Health Platform, Gill Bashe to assume role of Editor in Chief as Medika strives to continue it founding goals.

ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Men with prostate cancer need the right diet and a consistent exercise routine to help them manage their weight. Studies show that overweight men often have worse prostate cancer outcomes

People hospitalized with COVID-19 and neurological problems including stroke and confusion, have a higher risk of dying than other COVID-19 patients